
### [MONDO:0015490](http://purl.obolibrary.org/obo/MONDO_0015490)
**Label:** predominantly small-vessel vasculitis

**Subclasses:** [MONDO:0019526](http://purl.obolibrary.org/obo/MONDO_0019526) (erythema elevatum diutinum), [MONDO:0018227](http://purl.obolibrary.org/obo/MONDO_0018227) (hypocomplementemic urticarial vasculitis), [MONDO:0019124](http://purl.obolibrary.org/obo/MONDO_0019124) (microscopic polyangiitis), [MONDO:0015491](http://purl.obolibrary.org/obo/MONDO_0015491) (immune complex mediated vasculitis), [MONDO:0019167](http://purl.obolibrary.org/obo/MONDO_0019167) (immunoglobulin a vasculitis), [MONDO:0009303](http://purl.obolibrary.org/obo/MONDO_0009303) (anti-glomerular basement membrane disease), [MONDO:0015492](http://purl.obolibrary.org/obo/MONDO_0015492) (Anti-neutrophil cytoplasmic antibody-associated vasculitis), [MONDO:0007407](http://purl.obolibrary.org/obo/MONDO_0007407) (Cryoglobulinemic vasculitis), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0015943](http://purl.obolibrary.org/obo/MONDO_0015943) (eosinophilic granulomatosis with polyangiitis), [MONDO:0019509](http://purl.obolibrary.org/obo/MONDO_0019509) (cutaneous leukocytoclastic angiitis), [MONDO:0019726](http://purl.obolibrary.org/obo/MONDO_0019726) (type II mixed cryoglobulinemia), [MONDO:0014405](http://purl.obolibrary.org/obo/MONDO_0014405) (STING-associated vasculopathy with onset in infancy), [MONDO:0019727](http://purl.obolibrary.org/obo/MONDO_0019727) (mixed cryoglobulinemia type III), 

**Mapped go classes:** [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0032606](http://purl.obolibrary.org/obo/GO_0032606) (type I interferon production), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:0032608](http://purl.obolibrary.org/obo/GO_0032608) (interferon-beta production), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0035438](http://purl.obolibrary.org/obo/GO_0035438) (cyclic-di-GMP binding), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0061507](http://purl.obolibrary.org/obo/GO_0061507) (cyclic-GMP-AMP binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0071360](http://purl.obolibrary.org/obo/GO_0071360) (cellular response to exogenous dsRNA), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0039528](http://purl.obolibrary.org/obo/GO_0039528) (cytoplasmic pattern recognition receptor signaling pathway in response to virus), 

**Class expressions from DL-Learner:**

- [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane) 54.17%
- [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 54.17%
- [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 54.17%
- [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) and [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane) 54.17%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 54.17%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 54.17%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) 54.17%
- Thing 52.22%
- [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane) 39.52%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) 39.52%
- [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 39.52%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0098805](http://purl.obolibrary.org/obo/GO_0098805) (whole membrane) 39.52%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0098588](http://purl.obolibrary.org/obo/GO_0098588) (bounding membrane of organelle) 39.52%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 39.52%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 39.52%


